The WACC of Innate Pharma SA (IPH.PA) is 5.4%.
| Range | Selected | |
| Cost of equity | 5.70% - 8.00% | 6.85% |
| Tax rate | 25.90% - 27.10% | 26.50% |
| Cost of debt | 4.00% - 4.50% | 4.25% |
| WACC | 4.6% - 6.2% | 5.4% |
| Category | Low | High |
| Long-term bond rate | 3.0% | 3.5% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.46 | 0.58 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.70% | 8.00% |
| Tax rate | 25.90% | 27.10% |
| Debt/Equity ratio | 0.6 | 0.6 |
| Cost of debt | 4.00% | 4.50% |
| After-tax WACC | 4.6% | 6.2% |
| Selected WACC | 5.4% | |